Pharmacists in Raleigh, North Carolina


588 Pharmacists found in Raleigh
female pharmacist

Viola Daoud


Pharmacist
3220 Spring Forest Rd, Raleigh, NC 27616
919-544-3896    

female pharmacist

Dr. Wendy Ann Hagwood, PHARMD


Pharmacist
4500 Western Blvd, Kmart Pharmacy #4450, Raleigh, NC 27606
919-851-5247     919-859-4357

female pharmacist

Wendy Lynette Haun, RPH


Pharmacist
2601 Blue Ridge Rd, Raleigh, NC 27607
919-781-7986     919-781-1833



male pharmacist

Mr. William Plumer Parker Ii, RPH


Pharmacist
1219 Buck Jones Rd, Raleigh, NC 27606
919-467-6364     919-467-2796

male pharmacist

William Chapman Jr., RPH


Pharmacist
1540 Sunday Dr, First Floor, Raleigh, NC 27607
919-325-4275    

male pharmacist

Mr. William Scott Varner, RPH


Pharmacist
7905 Falls Of Neuse Rd, Raleigh, NC 27615
919-847-4178     919-847-8024

male pharmacist

William Edwward Cash Jr., PHARM D


Pharmacist
4841 Grove Barton Rd, T-1080, Raleigh, NC 27613
919-785-0335     919-785-0335

male pharmacist

William D Lindsay, R PH


Pharmacist
543 Pylon Dr, Raleigh, NC 27606
919-833-3993     800-571-3991

male pharmacist

Wren Whitney Berney, PHARMD


Pharmacist
7900 Old Wake Forest Rd, Raleigh, NC 27616
919-790-9689     919-714-8802

male pharmacist

Youhanna Youssef


Pharmacist
3019 Falstaff Rd, Raleigh, NC 27610
919-250-7000    

female pharmacist

Yukying Cheung, PHARMD


Pharmacist - Pharmacotherapy
3000 New Bern Ave, Raleigh, NC 27610
919-350-5880    

female pharmacist

Zahra Nassehzadeh-tabrizi, PHARMD


Pharmacist
11201 Durant Rd, Raleigh, NC 27614
919-518-0514     919-518-0981


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.